Stocks
ALX Oncology Holdings (ALXO) EV/EBITDA US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | -6.03 | -1.65 | -3.00 | 0.18 | -0.21 | -3.78 | ||
| Changes by years, y/y, % | -91% | -73% | +81% | -106% | -217% | -68.7% | |||
ALX Oncology Holdings. EV/EBITDA
ALX Oncology Holdings. EV/EBITDA, changes, %
ALX Oncology Holdings (ALXO) EV/EBITDA US GAAP (quarter values) |
||||||||
| 2024Q4 | 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | LTM ? | |||
| EV/EBITDA | ? | 0.22 | 0.43 | 0.36 | -0.40 | -0.22 | -3.78 | |
| Changes by years, y/y, % | -106% | -117% | -135% | -237% | -197% | |||
| Changes by quarters, q/q, % | -22% | +91% | -16% | -210% | -45% | |||
